# Haematologic Technologies, LLC dba Prolytix – FDA Inspection, Jun 27, 2019

Source: https://www.keypedia.com/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/50ca8d3d-8097-4872-aed7-441384aec950
Source feed: FDA_Inspections

> FDA inspection 1098078 of Haematologic Technologies, LLC dba Prolytix, June 27, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1098078
- Company Name: Haematologic Technologies, LLC dba Prolytix
- Inspection Date: 2019-06-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1314930 - 2026-04-17](https://www.keypedia.com/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/0542f691-8e6c-4a69-b14f-629cd185c8ad)
- FDA Inspection 1258523 - 2025-01-06
- FDA Inspection 1147450 - 2021-07-30
- FDA Inspection 1027695 - 2017-07-28
- [FDA Inspection 1013147 - 2017-05-11](https://www.keypedia.com/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/c6e6dd3e-5093-458a-9a69-6b09b1f005a4)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8)
- [Issuing Officer](https://www.keypedia.com/people/jason-d-abel/42c4bafe-17bb-4a43-80cd-83dd77b3426d)

Company: https://www.keypedia.com/companies/haematologic-technologies-llc-dba-prolytix/03297ca5-f207-401a-8202-1b343903beed

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
